FP7H2020HORIZON
Inserm Transfert SA
- Country
- FRFrance
- Defence projects
- 0
- Projects, all programmes
- 100
- As coordinator
- 2
- EU contribution (CORDIS)
- EUR 33,709,323
- Active
- 2007 to 2025
Projects
100 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| HPV-FASTER-ImplementOffering combined HPV vaccination and HPV test-based cervical screening to vulnerable populations. A hybrid efficacy and implementation study. | HORIZON | 2025 | Participant | EUR 354,549 |
| BE READY PLUSBuilding a European strategic Research and Innovation Area in Direct Synergy with EU and International Initiatives for Pandemic Preparedness PLUS | HORIZON | 2025 | Participant | EUR 108,025 |
| EXPOSIGNALZDissecting Brain Pollutant Exposure and its Contribution to Neurodegeneration and Alzheimer’s disease: From Signatures to Prevention Strategies to Protect and Maintain a Healthy Brain | HORIZON | 2025 | Participant | EUR 393,000 |
| PROACT EU-ResponseA European Proactive Adaptive Clinical Trials Network within EU-Response | HORIZON | 2025 | Participant | EUR 516,413 |
| SERENAAssessing and improving access to health and social care SErvices for children RENdered vulnerable by Abuse | HORIZON | 2025 | Participant | EUR 397,640 |
| IMPROVE PRETERMIMPROVing lifElong health and development for children and adults born very PRETERM – observational studies to enhance randomised trials for comparative effectiveness research | HORIZON | 2025 | Participant | EUR 393,745 |
| INVENTSInnovative designs, extrapolation, simulation methods and evidence-tools for rare diseases addressing regulatory needs | HORIZON | 2024 | Participant | EUR 411,375 |
| INTERCEPT-T2DEarly Interception of Inflammatory-mediated Type 2 Diabetes | HORIZON | 2023 | Participant | EUR 400,375 |
| HT-ADVANCEImproving treatment efficacy in hypertension by biomarker-guided personalised decision support | HORIZON | 2023 | Participant | EUR 924,250 |
| CARE-IN-HEALTHCArdiovascularREsolution of INflammation to promote HEALTH | HORIZON | 2023 | Participant | EUR 438,125 |
| ARTiDeAutoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe) | HORIZON | 2023 | Participant | EUR 352,125 |
| OBELISKFighting childhood obesity to stay healthy all over the life | HORIZON | 2023 | Participant | EUR 512,750 |
| MITI 2Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy (MITI2) | HORIZON | 2023 | Participant | EUR 467,934 |
| MPX-RESPONSEA clinical research network to improve the management of Monkeypox virus disease | HORIZON | 2022 | Participant | EUR 335,123 |
| REGeRNACardiac regeneration by mRNA-triggered proliferation of cardiomyocytes | HORIZON | 2022 | Participant | EUR 396,975 |
| BE READYBuilding a European strategic Research and Innovation Area in Direct Synergy with EU and International Initiatives for Pandemic Preparedness | HORIZON | 2022 | Participant | EUR 198,375 |
| HERVCOVSARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients | HORIZON | 2022 | Participant | EUR 356,500 |
| 4.UNCAN.euA Coordination and Support Action to prepare UNCAN.eu platform | HORIZON | 2022 | Participant | EUR 217,500 |
| ISIDOReIntegrated Services for Infectious Disease Outbreak Research | HORIZON | 2022 | Participant | EUR 297,918 |
| CBIG-SCREENWorking collaboratively with vulnerable women to identify the best implementation gains by screening cervical cancer more effectively in European countries | H2020 | 2021 | Participant | EUR 254,500 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.